Orchestra BioMed Holdings

OBIO62

$5.30arrow_drop_up8.38%$0.41

OBIO62

$5.30

arrow_drop_up8.38%$0.41

Performance History

Key Stats
Open	$5.12
Prev. Close	$5.82
EPS	-1.56
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$220.13M
PE Ratio	-

	LOW	HIGH
Day Range	4.48	5.55
52 Week Range	4.22	11.69

Ratios







EPS	-1.56

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Orchestra BioMed Holdings (OBIO)

Health Sciences Acquisitions Corporation 2 (OBIO) is a healthcare-focused special purpose acquisition corporation (SPAC) that completed its initial public offering on May 26, 2021. The company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. Health Sciences Acquisitions Corporation 2 is led by a team of experienced professionals with extensive backgrounds in the healthcare industry. The company's goal is to identify and acquire a target business that can benefit from its operational and strategic expertise.

As of the latest market close, Health Sciences Acquisitions Corporation 2 has a market capitalization of $XX billion. The company's stock, OBIO, has a 52-week range of $X-$X, with a day range of $X-$X. The trading volume for OBIO stock is approximately X.X million shares. Health Sciences Acquisitions Corporation 2 competes in the healthcare industry, which includes companies involved in pharmaceuticals, biotechnology, medical devices, healthcare services, and other related sectors.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. David P. Hochman
Headquarters: New Hope
Employees: 0
Exchange: NASDAQ

add Orchestra BioMed Holdings to watchlist

Keep an eye on Orchestra BioMed Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Orchestra BioMed Holdings's (OBIO) price per share?

The current price per share for Orchestra BioMed Holdings (OBIO) is $5.3. The stock has seen a price change of $0.41 recently, indicating a 8.38% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Orchestra BioMed Holdings (OBIO)?

For Orchestra BioMed Holdings (OBIO), the 52-week high is $11.69, which is 120.57% from the current price. The 52-week low is $4.22, the current price is 25.59% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Orchestra BioMed Holdings (OBIO) a growth stock?

Orchestra BioMed Holdings (OBIO) has shown an average price growth of 0.41% over the past three years. It has received a score of 37 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Orchestra BioMed Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Orchestra BioMed Holdings (OBIO) stock price performance year to date (YTD)?

As of the latest data, Orchestra BioMed Holdings (OBIO) has a year-to-date price change of -39.64%. Over the past month, the stock has experienced a price change of -17.06%. Over the last three months, the change has been -28.76%. Over the past six months, the figure is -1.12%.

help

Is Orchestra BioMed Holdings (OBIO) a profitable company?

Orchestra BioMed Holdings (OBIO) has a net income of -$49.12M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 88.06% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.17K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.76M, although specific revenue growth data is currently not available. The gross profit is $2.43M. Operating income is noted at -$51.51M. Furthermore, the EBITDA is -$58M.

help

What is the market capitalization of Orchestra BioMed Holdings (OBIO)?

Orchestra BioMed Holdings (OBIO) has a market capitalization of $186.1M. The average daily trading volume is 78.46K, indicating the stock's liquidity and investor engagement.